This circumvents the limitations imposed by the lack of zebrafish-specific tools, such as antibodies for flow cytometry or for western blot confirmation, and the apparent absence of certain key genes that regulate human oncogenic pathways, such as the BRCA1 and INK4a/ARF tumor suppressors (Howe et al., 2013). Here, CDKN2A is linked to neoplasm.